Skip to content

Effect of consumption of Gonal-F and Menogan on the fertility of infertile patients with Polycystic Ovary Syndrome

Comparison of pregnancy outcomes in infertile patients with polycystic ovarian syndrome receiving Menogon monotherapy alone and in patients receiving Gonal-F and Menogon for ovulation induction in women

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171030037093N10
Enrollment
100
Registered
2019-05-07
Start date
2019-06-02
Completion date
Unknown
Last updated
2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: For the first group, manogan injections containing 75 units of LH and 75 units of FSH were injected once a day and for 10-12 days. Intervention 2: Intervention grou

Sponsors

Vice chancellor for research, Shahrekord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 40 Years

Inclusion criteria

Inclusion criteria: Infection with polycystic ovary syndrome Age less than 40 years Induction of in vitro fertilization No response to treatment with clomiphene citrate in patients

Exclusion criteria

Exclusion criteria: Blocking both tubes as the cause of infertility Hypothalamic amenorrhea as the cause of infertility Early ovarian failure as the cause of infertility Infertility due to severe male or azoospermia Diabetes Problems with thyroid problems Kidney Disease Sensitization to letrozole and clomiphene

Design outcomes

Primary

MeasureTime frame
The number of ocits earned. Timepoint: 7 and 12 days after the intervention. Method of measurement: Vaginal ultrasound.;Endometrial thickness. Timepoint: 7 and 12 days after the intervention. Method of measurement: Measurement.;Number of cases of empty follicular syndrome. Timepoint: 7 and 12 days after the intervention. Method of measurement: Vaginal ultrasound.;The number of cases of ovarian hyperstimulation syndrome. Timepoint: 7 and 12 days after the intervention. Method of measurement: Based on the amount of free fluid in the abdomen with ultrasound.;Human Chorionic Gonadotropin. Timepoint: 16 days after the transfer of embryos. Method of measurement: Experiment.;Fetal heart rate. Timepoint: 6 weeks after fertilization. Method of measurement: FHR machine.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Nemati

Shahre-kord University of Medical Sciences

Mertanem@yahoo.co.uk+98 38 3222 0478

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026